Resources

The American Diabetes Association (ADA) has issued new practice guidelines for screening, diagnostic, and therapeutic interventions that are known or believed to improve health outcomes of patients with diabetes.

The DPP-IV inhibitor vildagliptin (Galvus) is effective monotherapy for treatment-naive elderly patients with type 2 diabetes, according to a report in the December issue of Diabetes Care.

“Biennial screening examinations suffice in both type 1 and type 2 patients with diabetes without retinopathy is effective.

Diabetes treatment could get a whole lot easier to swallow. Dr. Robert Doyle, assistant professor of chemistry at Syracuse University has designed, tested, reproduced and patented a system for delivering insulin through an oral pill.

New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies have never published those results.

Smoked cannabis eased pain induced in healthy volunteers, according to a study by researchers at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR.) However, the researchers found that less may be more.

A provocative study presented at the AHA has found an association between long-term use of birth control pills and buildup of plaque in arteries in the neck and legs, which could be a sign of heart disease.

Jump Start Consulting has some great ideas to help us start the New Year, Be sure to read BUSINESS RESOLUTIONS FOR THE NEW YEAR and learn how to improve patient rapport and compliance in 2008 BUSINESS RESOLUTIONS FOR THE NEW YEAR  INCREASING PATIENT RAPPORT AND COMPLIANCE Beverly Price, RD, MA, …

For overweight or obese individuals who are physically inactive, brisk walking might be the best exercise prescription for shedding excess pounds and reducing the risk of metabolic syndrome and prediabetes.

A new study confirms that chronic kidney disease (CKD) increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the anti-diabetic drug pioglitazone may help to lower this risk.